Amgen Inc. (AMGN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Amgen Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Amgen Inc. (AMGN) has returned 8.24% so far this year and 16.48% over the past 12 months. Over the last ten years, AMGN has had an annualized return of 11.88%, just under the S&P 500 Index benchmark’s 12.16%.

Based on dividend-adjusted daily data since Sep 7, 1984, AMGN's average daily return is +0.11%, while the average monthly return is +2.19%. At this rate, your investment would double in approximately 2.7 years.

Historically, 58% of months were positive and 42% were negative. The best month was Dec 1987 with a return of +45.9%, while the worst month was Feb 1993 at -41.5%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 5 months.

On a daily basis, AMGN closed higher 49% of trading days. The best single day was Oct 28, 1987 with a return of +25.3%, while the worst single day was Feb 25, 1993 at -20.0%.

Amgen Inc. has an annualized alpha of 19.92%, beta of 0.88, and R² of 0.18 versus S&P 500 Index. Calculated based on daily prices since September 10, 1984.

• This stock captured 117.08% of S&P 500 Index gains but only 54.26% of its losses — a favorable profile for investors.
• R² of 0.18 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

AMGN ranks 60 for risk / return — better than 60% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Amgen Inc. (AMGN) and compare them to a chosen benchmark (S&P 500 Index).

Amgen Inc. provided a 2.75% dividend yield over the last twelve months, with an annual payout of $9.66 per share. The company has been increasing its dividends for 14 consecutive years.

The table displays the monthly dividend distributions for Amgen Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Amgen Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Amgen Inc. was 63.48%, occurring on Oct 26, 1987. Recovery took 405 trading sessions.

The current Amgen Inc. drawdown is 9.35%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Amgen Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Amgen Inc. is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.